Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Authors
Keywords
-
Journal
JOURNAL OF LIPID RESEARCH
Volume 53, Issue 9, Pages 1723-1737
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2012-05-02
DOI
10.1194/jlr.r024794
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis inob/obMice
- (2012) Yanqiao Zhang et al. MOLECULAR ENDOCRINOLOGY
- Effect of Colesevelam Hydrochloride on Glycemia and Insulin Sensitivity in Men With the Metabolic Syndrome
- (2011) Gloria Lena Vega et al. AMERICAN JOURNAL OF CARDIOLOGY
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
- (2011) Thijs W.H. Pols et al. Cell Metabolism
- Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
- (2011) J. Prawitt et al. DIABETES
- Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus
- (2011) R. R. Henry et al. DIABETES OBESITY & METABOLISM
- Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study
- (2011) C. Beysen et al. DIABETOLOGIA
- Colesevelam Hydrochloride Added to Background Metformin Therapy in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis from 3 Clinical Studies
- (2011) Harold Bays Endocrine Practice
- Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output
- (2011) Anna Baghdasaryan et al. HEPATOLOGY
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
- (2011) Mitsuhiro Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Farnesoid X receptor represses hepatic human APOA gene expression
- (2011) Indumathi Chennamsetty et al. JOURNAL OF CLINICAL INVESTIGATION
- Studies in mice, hamsters, and rats demonstrate that repression of hepatic apoA-I expression by taurocholic acid in mice is not mediated by the farnesoid-X-receptor
- (2011) Christophe Gardès et al. JOURNAL OF LIPID RESEARCH
- The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
- (2011) Tingting Li et al. MOLECULAR ENDOCRINOLOGY
- Progress and challenges in translating the biology of atherosclerosis
- (2011) Peter Libby et al. NATURE
- Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate
- (2011) Maxi Meissner et al. PLoS One
- The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
- (2011) Sabrina Cipriani et al. PLoS One
- Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1
- (2010) Quan Shang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The bile acid sensor FXR regulates insulin transcription and secretion
- (2010) Barbara Renga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes
- (2010) Verena Keitel et al. BIOLOGICAL CHEMISTRY
- Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists
- (2010) Ulrich Abel et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5
- (2010) Mark R. Herbert et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene
- (2010) Jonathan Y. Bass et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Colesevelam Hydrochloride to Treat Hypercholesterolemia and Improve Glycemia in Prediabetes: A Randomized, Prospective Study
- (2010) Yehuda Handelsman et al. Endocrine Practice
- The nuclear receptor FXR is expressed in pancreatic β-cells and protects human islets from lipotoxicity
- (2010) Iuliana Ristea Popescu et al. FEBS LETTERS
- Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism
- (2010) Gemma Brufau et al. HEPATOLOGY
- The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin Pathways
- (2010) Mouaadh Abdelkarim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice
- (2010) Galya Vassileva et al. JOURNAL OF ENDOCRINOLOGY
- A fresh look at NASH pathogenesis. Part 1: The metabolic movers
- (2010) Claire Z Larter et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
- (2010) Thijs W.H. Pols et al. JOURNAL OF HEPATOLOGY
- Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates
- (2010) Joseph T. Lundquist et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Effect of Colesevelam Hydrochloride on Insulin Sensitivity and Secretion in Patients With Type 2 Diabetes: A Pilot Study
- (2010) Sherwyn L. Schwartz et al. Metabolic Syndrome and Related Disorders
- Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
- (2010) G. Rizzo et al. MOLECULAR PHARMACOLOGY
- A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
- (2009) Mark J. Evans et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
- (2009) Jongsook Kim Kemper et al. Cell Metabolism
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders
- (2009) Verena Keitel et al. HEPATOLOGY
- Bile salt sequestration induces hepaticde novolipogenesis through farnesoid X receptor- and liver X receptorα-controlled metabolic pathways in mice
- (2009) Hilde Herrema et al. HEPATOLOGY
- Treatment of nonalcoholic steatohepatitis with colestimide
- (2009) Makiko Taniai et al. HEPATOLOGY RESEARCH
- Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia
- (2009) Yanqiao Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Increased Flux through the Glucose 6-Phosphate Pool in Enterocytes Delays Glucose Absorption inFxr–/–Mice
- (2009) Theo H. van Dijk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Colestimide, an anion exchange resin agent, can decrease the number of LDL particles without affecting their size in patients with hyperlipidemia
- (2009) Noriaki Kishimoto et al. Journal of Cardiology
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR−/−and apoE−/−mice
- (2009) Helen B. Hartman et al. JOURNAL OF LIPID RESEARCH
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 Receptor Agonists
- (2009) Karen A. Evans et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
- (2009) Roberto Pellicciari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
- (2009) Brenton Flatt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure−Activity Relationship Study of Betulinic Acid, A Novel and Selective TGR5 Agonist, and Its Synthetic Derivatives: Potential Impact in Diabetes¶
- (2009) Cédric Genet et al. JOURNAL OF MEDICINAL CHEMISTRY
- Coordinated Regulation of Dimethylarginine Dimethylaminohydrolase-1 and Cationic Amino Acid Transporter-1 by Farnesoid X Receptor in Mouse Liver and Kidney and Its Implication in the Control of Blood Levels of Asymmetric Dimethylarginine
- (2009) J. Li et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus
- (2009) Karsten Müssig et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Dietary procyanidins enhance transcriptional activity of bile acid-activated FXRin vitroand reduce triglyceridemiain vivoin a FXR-dependent manner
- (2009) Josep Maria Del Bas et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle
- (2008) Taiki Kida et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Antiatherosclerotic effect of farnesoid X receptor
- (2008) Andrea Mencarelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Receiving Insulin-Based Therapy
- (2008) Ronald B. Goldberg ARCHIVES OF INTERNAL MEDICINE
- Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With Metformin
- (2008) Harold E. Bays et al. ARCHIVES OF INTERNAL MEDICINE
- Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes
- (2008) Robert S. Rosenson et al. ATHEROSCLEROSIS
- Expression and function of the bile acid receptor TGR5 in Kupffer cells
- (2008) Verena Keitel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064
- (2008) Adwoa Akwabi-Ameyaw et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy
- (2008) V. A. Fonseca et al. DIABETES CARE
- Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes
- (2008) Cédric Langhi et al. FEBS LETTERS
- Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies
- (2008) Hiroyuki Sato et al. JOURNAL OF MEDICINAL CHEMISTRY
- Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
- (2008) B. Kong et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity
- (2008) Romain Gineste et al. MOLECULAR ENDOCRINOLOGY
- Dietary procyanidins lower triglyceride levels signaling through the nuclear receptor small heterodimer partner
- (2008) Josep Maria Del Bas et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Targeting bile-acid signalling for metabolic diseases
- (2008) Charles Thomas et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation
- (2008) S. M. Soisson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now